1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Spinal Muscular Atrophy Treatment Market
2.3. Global Spinal Muscular Atrophy Treatment Market, By Type, 2025 (US$ Million)
2.4. Global Spinal Muscular Atrophy Treatment Market, By Application, 2025 (US$ Million)
2.5. Global Spinal Muscular Atrophy Treatment Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Spinal Muscular Atrophy Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Spinal Muscular Atrophy Treatment Market Vendors
3.2. Strategies Adopted by Spinal Muscular Atrophy Treatment Market Vendors
4. Spinal Muscular Atrophy Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Spinal Muscular Atrophy Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Type I Spinal Muscular Atrophy
5.3.2. Type II Spinal Muscular Atrophy
5.3.3. Type III Spinal Muscular Atrophy
6. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Gene Therapy
6.3.2. Drugs
7. North America Spinal Muscular Atrophy Treatment Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
7.3. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
7.4. Spinal Muscular Atrophy Treatment Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
7.4.1.1.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
7.4.1.2.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
7.4.1.3.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8. UK and European Union Spinal Muscular Atrophy Treatment Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.3. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4. Spinal Muscular Atrophy Treatment Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.1.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.2.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.3.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.4.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.5.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
8.4.1.6.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9. Asia Pacific Spinal Muscular Atrophy Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.3. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4. Spinal Muscular Atrophy Treatment Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.1.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.2.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.3.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.4.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.5.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
9.4.1.6.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
10. Latin America Spinal Muscular Atrophy Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
10.3. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
10.4. Spinal Muscular Atrophy Treatment Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
10.4.1.1.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
10.4.1.2.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
10.4.1.3.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
11. Middle East and Africa Spinal Muscular Atrophy Treatment Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
11.3. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
11.4. Spinal Muscular Atrophy Treatment Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
11.4.1.1.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
11.4.1.2.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Spinal Muscular Atrophy Treatment Market: By Type, 2024-2034, USD (Million)
11.4.1.3.2. Spinal Muscular Atrophy Treatment Market: By Application, 2024-2034, USD (Million)
12. Company Profile
12.1. Biogen Idec. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Pfizer Inc.
12.3. Boehringer Ingelheim
12.4. Isis Pharmaceuticals
12.5. F. Hoffmann-La Roche
12.6. Regeneron Pharmaceuticals
12.7. AveXis Inc.
12.8. Novartis AG
